Literature DB >> 8483419

Positive transcriptional control of mry regulates virulence in the group A streptococcus.

N Okada1, R T Geist, M G Caparon.   

Abstract

Transcription of the antiphagocytic M protein in the group A streptococcus (Streptococcus pyogenes) is environmentally regulated in response to CO2 and requires Mry, a trans-acting positive regulatory protein. We have examined the role of Mry in environmental regulation by analysing the factors that regulate expression of the gene that encodes Mry (mry). By employing a strategy that utilizes integrational plasmids, it was found that expression of mry requires the participation of DNA sequences that extend 473 base pairs upstream of the Mry coding region. Transcription of mry, as analysed in S1 nuclease protection assays, is initiated from two separate promoters located within this extended regulatory region. Construction and analysis of transcriptional fusions between the mry promoters and a promoterless chloramphenicol acetyltransferase gene demonstrated that mry is autoregulated and environmentally regulated in response to the level of CO2. These data suggest a model for the regulation of virulence in S. pyogenes where positive transcriptional control of mry in response to environmental stimuli regulates the expression of the M protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483419     DOI: 10.1111/j.1365-2958.1993.tb01180.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  58 in total

1.  Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding.

Authors:  Christiane Beckmann; Joshua D Waggoner; Theresa O Harris; Glen S Tamura; Craig E Rubens
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  The Delta subunit of RNA polymerase is required for virulence of Streptococcus agalactiae.

Authors:  Amanda L Jones; Rachel H V Needham; Craig E Rubens
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

3.  MtaR, a regulator of methionine transport, is critical for survival of group B streptococcus in vivo.

Authors:  Daniel Shelver; Lakshmi Rajagopal; Theresa O Harris; Craig E Rubens
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

4.  Identification of isp, a locus encoding an immunogenic secreted protein conserved among group A streptococci.

Authors:  K S McIver; S Subbarao; E M Kellner; A S Heath; J R Scott
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo.

Authors:  S U Kazmi; R Kansal; R K Aziz; M Hooshdaran; A Norrby-Teglund; D E Low; A B Halim; M Kotb
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Constitutive expression of fibronectin binding in Streptococcus pyogenes as a result of anaerobic activation of rofA.

Authors:  G C Fogg; M G Caparon
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

7.  Identification of residues responsible for the defective virulence gene regulator Mga produced by a natural mutant of Streptococcus pyogenes.

Authors:  Cheryl M Vahling; Kevin S McIver
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

8.  Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.

Authors:  D O Chaffin; L M Mentele; C E Rubens
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

9.  The group A streptococcal virR49 gene controls expression of four structural vir regulon genes.

Authors:  A Podbielski; A Flosdorff; J Weber-Heynemann
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus.

Authors:  K S McIver; A S Heath; B D Green; J R Scott
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.